Celcuity Other Operating Expenses (Quarterly) Analysis

Celcuity, Inc. (CELC)

114.48 +10.27 (+9.86%) USD | NASDAQ | Jan 14, 16:00

117.92 +3.44 (+3.00%) After-Hours: 06:04

View Other Operating Expenses (Quarterly) for CELC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Olema Pharmaceuticals, Inc.	--
Replimune Group, Inc.	Upgrade
Arrowhead Pharmaceuticals, Inc.	--
Cidara Therapeutics, Inc.	--
Cogent Biosciences, Inc.	--